Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals. Par is a portfolio company of TPG, a leading global private investment firm with $55.7 billion of assets under management and with extensive experience in the healthcare sector.
Editors [1]
The following is the list of scholars from PAR Sterile Products who currently serve as editors for one or more SciTechnol journals.
Publications [5]
The following is the list of articles by scholars from PAR Sterile Products that are published in SciTechnol journals.
-
Nanoparticle Formulation of Brusatol: A Novel Therapeutic Option for Cancers
Research Article: J Pharm Drug Deliv Res 2018
DOI: 10.4172/2325-9604.1000174
Simeon K. Adesina
-
Application of Acoustic- Vibratory Milling For Screening and Scale-Up of Micro/ Nanosuspensions in Early Drug Discovery and Development
Research Article: J Pharm Drug Deliv Res 2018
DOI: 10.4172/2325-9604.1000175
Hoang D Lu
-
Recombinant Human Insulin- PLGA NP Administered Orally after Combination with a Protease Inhibitor (N-Ethylmaleimide) in vivo Results
Letter to Editor: J Pharm Drug Deliv Res 2018, 7:1
DOI: 10.4172/2325-9604.1000176
Abdelkader DH, El-Gizawyb SA, Faheemc AM, McCarrona PA, OsmanbK MA
-
Development and Validation of a Chromatographic Method for the Quantification of Isoniazid in Human Plasma
Research Article: J Pharm Drug Deliv Res 2018, 7:1
DOI: 10.4172/2325-9604.1000177
Alshaikheid M, Fredj NB, Chaabane A, Chadli Z, Slama A, Boughattas N, Lassoued MA, Aouam K
-
Pharmacognostic Study of Seeds of Aconitum chasmanthum Stapf ex Holmes. A Wild Medicinal Plant of Neelum Valley Azad Jammu & Kashmir Pakistan
Research Article: J Pharm Drug Deliv Res 2018, 7:1
DOI: 10.4172/2325-9604.1000178
Perveen A, Ijaz S, Ghaffar N